XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenue:    
Total revenue $ 7,697,190 $ 10,294,781
Cost of revenue:    
Total cost of revenue 6,152,398 8,355,162
Gross profit 1,544,792 1,939,619
Selling, general and administrative expenses:    
Research and development expense 934,939 498,000
Selling, advertising and promotional expense 1,847,489 2,779,404
General and administrative expense 4,935,170 5,465,553
Total selling, general and administrative expenses 7,717,598 8,742,957
Operating loss (6,172,806) (6,803,338)
Other income (expense):    
Interest income 15,477 71,362
Interest expense (5,664) (17,009)
Other income 25,393 43,440
Change in fair value of contingent consideration promissory notes 158,021 (56,050)
Change in fair value of short-term investments (84,818)
Change in fair value of warrant derivative liabilities 148,171
Total other income 193,227 105,096
Income (loss) before income tax benefit (5,979,579) (6,698,242)
Income tax benefit
Net loss (5,979,579) (6,698,242)
Net (income) loss attributable to noncontrolling interests of consolidated subsidiary (126,239) 98,094
Net loss attributable to common stockholders $ (6,105,818) $ (6,600,148)
Net loss per share information:    
Basic $ (2.22) $ (2.59)
Diluted $ (2.22) $ (2.59)
Weighted average shares outstanding:    
Basic 2,751,662 2,546,552
Diluted 2,751,662 2,546,552
Product [Member]    
Revenue:    
Total revenue $ 2,453,810 $ 2,410,060
Cost of revenue:    
Total cost of revenue 2,301,100 2,822,051
Service, Other [Member]    
Revenue:    
Total revenue 5,243,380 7,884,721
Cost of revenue:    
Total cost of revenue $ 3,851,298 $ 5,533,111